Advertisement
Canada markets closed

  • S&P/TSX

    21,873.72
    -138.00 (-0.63%)
     

  • S&P 500

    5,071.63
    +1.08 (+0.02%)
     

  • DOW

    38,460.92
    -42.77 (-0.11%)
     

  • CAD/USD

    0.7297
    -0.0024 (-0.32%)
     

  • CRUDE OIL

    82.84
    +0.03 (+0.04%)
     

  • Bitcoin CAD

    88,180.02
    -2,831.48 (-3.11%)
     

  • CMC Crypto 200

    1,385.35
    -38.75 (-2.72%)
     

  • GOLD FUTURES

    2,328.90
    -9.50 (-0.41%)
     

  • RUSSELL 2000

    1,995.43
    -7.22 (-0.36%)
     

  • 10-Yr Bond

    4.6520
    +0.0540 (+1.17%)
     

  • NASDAQ futures

    17,507.25
    -99.50 (-0.57%)
     

  • VOLATILITY

    15.97
    +0.28 (+1.78%)
     

  • FTSE

    8,040.38
    -4.43 (-0.06%)
     

  • NIKKEI 225

    38,460.08
    +907.92 (+2.42%)
     

  • CAD/EUR

    0.6819
    -0.0017 (-0.25%)
     

Five Star Equities Issues New Research Reports on ACAS, CALM, CI and MNKD

ACCESSWIRE

Five Star Equities releases regular market updates so investors can stay ahead of the crowd and make the best investment decisions to maximize their returns. Take a few minutes to register with us free at www.FiveStarEquities.com and get exclusive access to our numerous stock reports.

American Capital Ltd. (NASDAQ:ACAS - News) shares surged 11.15 percent to close at $15.80 a share Monday. The stock traded between $14.50 and $16.00 on volume 13.09 million shares traded. The company announced that during the first quarter it purchased 8.9 million shares of its common stock at an average price of $15.38 a share. Shares of American Capital are up approximately 1.0 percent year-to-date.

Get more information on American Capital free access to the in-depth equity report at:
www.FiveStarEquities.com/ACAS

Cal-Maine Foods Inc. (NASDAQ:CALM - News) shares spiked 9.16 percent to close at $62.78 a share Monday. The stock traded between $59.70 and $64.22 on volume of 458,271 shares traded. The company reported a net income of $42.9 million for the third quarter of fiscal 2014, up from a net income of $30.6 million a year ago. Shares of Cal-Maine Foods are up approximately 4.0 percent year-to-date.

ADVERTISEMENT

Get more information on Cal-Maine Foods and free access to the in-depth equity report at:
www.FiveStarEquities.com/CALM

CIGNA Corporation (NYSE:CI - News) shares jumped 5.44 percent to close at $83.73 a share Monday. The stock traded between $80.13 and $84.28 on volume 5.91 million shares traded. J.P. Morgan analysts have recently raised the company's price target to $96.00 from $93.00. Shares of CIGNA are down approximately 4.0 percent year-to-date.

Get more information on CIGNA and free access to the in-depth equity report at:
www.FiveStarEquities.com/CI

MannKind Corporation (NASDAQ:MNKD - News) shares dropped 16.77 percent to close at $4.02 a share Monday. The stock traded between $3.80 and $4.60 on volume of 30.26 million shares traded. TheStreet's biotech expert Adam Feuerstein has recently stated that he sees a 40.0 percent chance that Afrezza is approved by the FDA for the treatment of type 1 diabetes. Shares of Cleantech Solutions are up approximately 18.0 percent year-to-date.

Get more information on MannKind and free access to the in-depth equity report at:
www.FiveStarEquities.com/MNKD

Disclaimer: Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor's reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. Five Star Equities has no financial relationship with any company whose stock is mentioned in this release.

Contact:
Five Star Equities
info@fivestarequities.com